Efficacy and safety profile of intravenous tocilizumab versus intravenous abatacept in treating female Saudi Arabian patients with active moderate-to-severe rheumatoid arthritis-Reference-Cited by-同舟云学术

Efficacy and safety profile of intravenous tocilizumab versus intravenous abatacept in treating female Saudi Arabian patients with active moderate-to-severe rheumatoid arthritis

Published:2019-03-26 Issue:8 Volume:38 Page:2109-2117
ISSN:0770-3198
Container-title:Clinical Rheumatology
language:en
Short-container-title:Clin Rheumatol

Author:

Elmedany Samah Hamdy,Mohamed Aly Elsayed,Galil Sahar Mahfouz Abdel^ORCID

Publisher

Springer Science and Business Media LLC

Subject

General Medicine,Rheumatology

Link

http://link.springer.com/content/pdf/10.1007/s10067-019-04508-2.pdf

Reference33 articles.

1. Giles J, Bathon JM (2010) Management of rheumatoid arthritis: synovitis. Rheumatology 1:955–963

2. Emery P, Breedveld FC, Hall S, Durez P, Chang DJ, Robertson D, Singh A, Pedersen RD, Koenig AS, Freundlich B (2008) Comparison of methotrexate monotherapy with a combination of methotrexate and etanercept in active, early, moderate to severe rheumatoid arthritis (COMET): a randomized, double-blind, parallel treatment trial. Lancet 372:375–382

3. Finckh A, Simard JF, Gabay C, Guerne PA (2006) Evidence for differential acquired drug resistance to anti-tumor necrosis factor agents in rheumatoid arthritis. Ann Rheum Dis 65:746–752

4. Du Pan SM, Dehler S, Ciurea A et al (2009) Comparison of drug retention rates and causes of drug discontinuation between anti-tumor necrosis factor agents in rheumatoid arthritis. Arthritis Rheum 61:560–568

5. Buch MH (2010) Sequential use of biologic therapy in rheumatoid arthritis. Curr Opin Rheumatol 22:321–329

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Actualización del Documento de Consenso de la Sociedad Española de Reumatología sobre el uso de terapias biológicas y sintéticas dirigidas en la artritis reumatoide;Reumatología Clínica;2024-07

2. Chemokines and chemokine receptors as promising targets in rheumatoid arthritis;Frontiers in Immunology;2023-02-13

3. Targeting inflammation in hypertension;Current Opinion in Nephrology & Hypertension;2022-12-07

4. Interleukin-6 blockade reduces salt-induced cardiac inflammation and fibrosis in subtotal nephrectomized mice;American Journal of Physiology-Renal Physiology;2022-12-01

5. Prevalence of adverse reactions to intravenously administered originator biologics in patients with rheumatoid arthritis: A 5-year retrospective study;Saudi Pharmaceutical Journal;2022-07